Wells Fargo & Company »

Acorda Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Acorda Therapeutics (ACOR) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Acorda Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acorda Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acorda Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $50k 3.7k 13.33
2023-12-31 $57k 3.7k 15.10
2023-09-30 $56k 3.7k 15.00
2023-06-30 $49k 3.7k 13.00